Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

The postanesthesia care unit: a high-risk environment for bloodborne and infectious respiratory pathogens.

Van Dyke RA.

J Perianesth Nurs. 1997 Oct;12(5):317-20. No abstract available.

PMID:
9370575
2.

Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide.

Sigmon DH, Florentino-Pineda I, Van Dyke RA, Beierwaltes WH.

Anesthesiology. 1995 Jan;82(1):135-43.

PMID:
7832295
3.

Vascular effects of halothane and isoflurane: cGMP dependent and independent actions.

Jing M, Hart JL, Masaki E, Van Dyke RA, Bina S, Muldoon SM.

Life Sci. 1995;56(1):19-29.

PMID:
7830493
4.
5.

Nuclear translocation of heat shock protein 72 in liver cells of halothane-exposed rats.

Lin WQ, Van Dyke RA, Marsh HM, Trudell JR.

Biochem Biophys Res Commun. 1994 Mar 15;199(2):647-52.

PMID:
8135806
6.

Effect of halothane on hypoxic toxicity and glutathione status in cultured rat hepatocytes.

Johnson ME, Sill JC, Uhl CB, Van Dyke RA.

Anesthesiology. 1993 Nov;79(5):1061-71.

PMID:
8238983
7.

Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations.

Hart JL, Jing M, Bina S, Freas W, Van Dyke RA, Muldoon SM.

Anesthesiology. 1993 Aug;79(2):323-31.

PMID:
8393633
8.

The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.

Sill JC, Eskuri S, Nelson R, Tarara J, Van Dyke RA.

J Pharmacol Exp Ther. 1993 Apr;265(1):74-80.

PMID:
8386245
9.

The effects of sevoflurane on intracellular Ca2+ regulation in rat hepatocytes.

Iaizzo PA, Seewald MJ, Powis G, Van Dyke RA.

Toxicol Lett. 1993 Jan;66(1):81-8.

PMID:
8427024
10.

Immunocytochemical detection of the 72-kDa heat shock protein in halothane--induced hepatotoxicity in rats.

Van Dyke RA, Mostafapour S, Marsh HM, Li Y, Chopp M.

Life Sci. 1992;50(7):PL41-5.

PMID:
1542250
11.

Transient increases of intracellular Ca2+ induced by volatile anesthetics in rat hepatocytes.

Iaizzo PA, Olsen RA, Seewald MJ, Powis G, Stier A, Van Dyke RA.

Cell Calcium. 1990 Sep;11(8):515-24.

PMID:
2265428
12.

The effects of volatile anesthetics on Ca++ mobilization in rat hepatocytes.

Iaizzo PA, Seewald MJ, Powis G, Van Dyke RA.

Anesthesiology. 1990 Mar;72(3):504-9.

PMID:
2310032
13.

Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity.

Lash LH, Nelson RM, Van Dyke RA, Anders MW.

Drug Metab Dispos. 1990 Jan-Feb;18(1):50-4.

PMID:
2139845
14.

Comparison of analgesic requirements after liver transplantation and cholecystectomy.

Eisenach JC, Plevak DJ, Van Dyke RA, Southorn PA, Danielson DR, Krom RA, Nagorney DM, Rettke SR.

Mayo Clin Proc. 1989 Mar;64(3):356-9.

PMID:
2649750
15.

Hemodynamic and metabolic changes in hepatic transplantation.

Rettke SR, Janossy TA, Chantigian RC, Burritt MF, Van Dyke RA, Harper JV, Ilstrup DM, Taswell HF, Wiesner RH, Krom RA.

Mayo Clin Proc. 1989 Feb;64(2):232-40.

PMID:
2646481
16.

Anesthesia approach to hepatic transplantation.

Rettke SR, Chantigian RC, Janossy TA, Burritt MF, Van Dyke RA, Harper JV, Ilstrup DM, Taswell HF, Wiesner RH, Krom RA.

Mayo Clin Proc. 1989 Feb;64(2):224-31.

PMID:
2646480
17.

Resonance Raman study of the cytochrome P-450 LM2-halothane intermediate complex.

Hildebrandt P, Garda H, Stier A, Stockburger M, Van Dyke RA.

FEBS Lett. 1988 Sep 12;237(1-2):15-20.

18.

Reductive metabolism of halothane by purified cytochrome P-450.

Van Dyke RA, Baker MT, Jansson I, Schenkman J.

Biochem Pharmacol. 1988 Jun 15;37(12):2357-61.

PMID:
3390202
19.

Isoflurane causes endothelium-dependent inhibition of contractile responses of canine coronary arteries.

Blaise G, Sill JC, Nugent M, Van Dyke RA, Vanhoutte PM.

Anesthesiology. 1987 Oct;67(4):513-7.

PMID:
3662080
20.

Human liver and conjugation of catecholamines.

Tyce GM, Van Dyke RA, Rettke SR, Atchison SR, Wiesner RH, Dickson ER, Krom RA.

J Lab Clin Med. 1987 May;109(5):532-7.

PMID:
3553391
21.

Stabilization of the reduced halocarbon-cytochrome P-450 complex of halothane by N-alkanes.

Baker MT, Bates JN, Van Dyke RA.

Biochem Pharmacol. 1987 Apr 1;36(7):1029-34.

PMID:
3566799
22.

Effect of inhalation anesthetics on antipyrine pharmacokinetics of mice.

Van Dyke RA, Kooistra KL, Moses CJ, Powis G.

Biochem Pharmacol. 1987 Apr 1;36(7):1023-7.

PMID:
3566798
23.
24.

Increased toxicity of the antitumor drug cyclophosphamide in mice in the presence of the volatile anesthetic agent halothane.

Rosenow S, Kooistra KL, Powis G, Van Dyke RA.

Cancer Chemother Pharmacol. 1986;16(1):35-42.

PMID:
3940218
25.

The formation of chlorobenzene and benzene by the reductive metabolism of lindane in rat liver microsomes.

Baker MT, Nelson RM, Van Dyke RA.

Arch Biochem Biophys. 1985 Feb 1;236(2):506-14.

PMID:
2578765
26.

Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.

Baker MT, Van Dyke RA.

Chem Biol Interact. 1984 Apr;49(1-2):121-32.

PMID:
6722932
27.
28.

The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.

Baker MT, Nelson RM, Van Dyke RA.

Drug Metab Dispos. 1983 Jul-Aug;11(4):308-11.

PMID:
6137335
29.

Cytochrome P-450 and halothane metabolism. Decrease in rat liver microsomal P-450 in vitro.

Krieter PA, van Dyke RA.

Chem Biol Interact. 1983 Jun;44(3):219-35.

PMID:
6872091
30.
31.

Phosphorylase ratio and susceptibility to malignant hyperthermia.

Traynor CA, Van Dyke RA, Gronert GA.

Anesth Analg. 1983 Mar;62(3):324-6.

PMID:
6299136
32.

Effect of oxygen concentration, hyperthermia, and choice of vendor on anesthetic-induced hepatic injury in rats.

Shingu K, Eger EI 2nd, Johnson BH, Van Dyke RA, Lurz FW, Cheng A.

Anesth Analg. 1983 Feb;62(2):146-50.

PMID:
6829915
33.

Hepatic injury induced by anesthetic agents in rats.

Shingu K, Eger EI 2nd, Johnson BH, Van Dyke RA, Lurz FW, Harper MH, Cheng A.

Anesth Analg. 1983 Feb;62(2):140-5.

PMID:
6829914
34.
35.

Microsomal lipids as targets for halothane metabolites.

Legler D, Van Dyke RA.

Res Commun Chem Pathol Pharmacol. 1982 Sep;37(3):395-402.

PMID:
7178651
36.
37.

Metabolism of anesthetic agents: toxic implications.

Van Dyke RA.

Acta Anaesthesiol Scand Suppl. 1982;75:7-9. No abstract available.

PMID:
6958162
38.

Toxic metabolites from biotransformation: major organ damage.

Van Dyke RA.

Int Anesthesiol Clin. 1981 Winter;19(4):39-67. No abstract available.

PMID:
7309251
39.

Brain pH measurements using a diffusible, lipid soluble pH sensitive fluorescent indicator.

Sundt TM, Anderson RE, Van Dyke RA.

J Neurochem. 1978 Sep;31(3):627-35. No abstract available.

PMID:
28382
40.

Halothane--a new perspective.

Van Dyke RA.

Anesthesiology. 1978 Mar;48(3):165-6. No abstract available.

PMID:
626420
41.

Dechloriation mechanisms of chlorinated olefins.

Van Dyke RA.

Environ Health Perspect. 1977 Dec;21:121-4.

42.

Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro.

Wood CL, Gandolfi AJ, Van Dyke RA.

Drug Metab Dispos. 1976 Jul-Aug;4(4):305-13.

PMID:
8284
43.

Gas embolism due to intravenous FC 80 liquid fluorocarbon.

Sass DJ, Van Dyke RA, Wood EH, Johnson SA, Didisheim P.

J Appl Physiol. 1976 May;40(5):745-51.

PMID:
931904
44.
45.
47.

Characteristics of a microsomal dechlorination system.

Van Dyke RA, Gandolfi AJ.

Mol Pharmacol. 1975 Nov;11(6):809-17. No abstract available.

PMID:
813109
48.

Metabolism of halothane.

Van Dyke RA.

Anesthesiology. 1975 Oct;43(4):386-7. No abstract available.

PMID:
1190516
49.

Venomotor changes caused by halothane acting on the sympathetic nerves.

Muldoon SM, Vanhoutte PM, Lorenz RR, Van Dyke RA.

Anesthesiology. 1975 Jul;43(1):41-8.

PMID:
238434
50.

Biochemical principles of the biotransformation of general anesthetics.

Van Dyke RA.

Acta Anaesthesiol Belg. 1975;23 Suppl:119-22. No abstract available.

PMID:
1231475

Supplemental Content

Loading ...
Support Center